HEADER TRANSCRIPTION 16-AUG-16 5T0T OBSLTE 25-JAN-17 5T0T 5UFP TITLE CRYSTAL STRUCTURE OF PT2399 BOUND TO HIF2A-B*:ARNT-B* COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 237-346; COMPND 5 SYNONYM: EPAS-1,BASIC-HELIX-LOOP-HELIX-PAS PROTEIN MOP2,CLASS E BASIC COMPND 6 HELIX-LOOP-HELIX PROTEIN 73,BHLHE73,HIF-1-ALPHA-LIKE FACTOR,HLF, COMPND 7 HYPOXIA-INDUCIBLE FACTOR 2-ALPHA,HIF2-ALPHA,MEMBER OF PAS PROTEIN 2, COMPND 8 PAS DOMAIN-CONTAINING PROTEIN 2; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: UNP RESIDUES 342-453; COMPND 15 SYNONYM: ARNT PROTEIN,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 2, COMPND 16 BHLHE2,DIOXIN RECEPTOR,NUCLEAR TRANSLOCATOR,HYPOXIA-INDUCIBLE FACTOR COMPND 17 1-BETA,HIF1-BETA; COMPND 18 ENGINEERED: YES; COMPND 19 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPAS1, BHLHE73, HIF2A, MOP2, PASD2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ARNT, BHLHE2; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HIF2 INHIBITOR HIF2 LIGAND PAS-B HYPOXIA INDUCIBLE FACTOR 2 EPAS1, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR X.DU REVDAT 4 25-JAN-17 5T0T 1 REVDAT 3 16-NOV-16 5T0T 1 JRNL REVDAT 2 21-SEP-16 5T0T 1 JRNL REVDAT 1 31-AUG-16 5T0T 0 JRNL AUTH H.CHO,X.DU,J.P.RIZZI,E.LIBERZON,A.A.CHAKRABORTY,W.GAO, JRNL AUTH 2 I.CARVO,S.SIGNORETTI,R.K.BRUICK,J.A.JOSEY,E.M.WALLACE, JRNL AUTH 3 W.G.KAELIN JRNL TITL ON-TARGET EFFICACY OF A HIF-2 ALPHA ANTAGONIST IN JRNL TITL 2 PRECLINICAL KIDNEY CANCER MODELS. JRNL REF NATURE V. 539 107 2016 JRNL REFN ESSN 1476-4687 JRNL PMID 27595393 JRNL DOI 10.1038/NATURE19795 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.CHEN,H.HILL,A.CHRISTIE,M.S.KIM,E.HOLLOMAN,A.PAVIA-JIMENEZ, REMARK 1 AUTH 2 F.HOMAYOUN,Y.MA,N.PATEL,P.YELL,G.HAO,Q.YOUSUF,A.JOYCE, REMARK 1 AUTH 3 I.PEDROSA,H.GEIGER,H.ZHANG,J.CHANG,K.H.GARDNER,R.K.BRUICK, REMARK 1 AUTH 4 C.REEVES,T.H.HWANG,K.COURTNEY,E.FRENKEL,X.SUN,N.ZOJWALLA, REMARK 1 AUTH 5 T.WONG,J.P.RIZZI,E.M.WALLACE,J.A.JOSEY,Y.XIE,X.J.XIE, REMARK 1 AUTH 6 P.KAPUR,R.M.MCKAY,J.BRUGAROLAS REMARK 1 TITL TARGETING RENAL CELL CARCINOMA WITH A HIF-2 ANTAGONIST. REMARK 1 REF NATURE 2016 REMARK 1 REFN ESSN 1476-4687 REMARK 1 PMID 27595394 REMARK 1 DOI 10.1038/NATURE19796 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.05 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 17988 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.325 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 613 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 703 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.4330 REMARK 3 BIN FREE R VALUE SET COUNT : 35 REMARK 3 BIN FREE R VALUE : 0.4340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1756 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 18 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.01000 REMARK 3 B22 (A**2) : -2.08000 REMARK 3 B33 (A**2) : -3.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.11000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.335 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.293 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.260 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.678 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1836 ; 0.015 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2486 ; 1.909 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 213 ; 7.586 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 95 ;37.446 ;24.211 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 315 ;18.935 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;19.734 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 265 ; 0.137 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1399 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5T0T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1000223395. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21779 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 31.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.54700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.209 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3F1P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MOTHER SOLUTION: BIS-TRIS PH5.4, 16% REMARK 280 PEG 3350 PROTEIN SOLUTION: 12~14 MG/ML IN 10 MM TRIS AND 50 MM REMARK 280 KCL, PH8.0, VAPOR DIFFUSION, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 36.70800 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.15700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 36.70800 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 42.15700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 48.23708 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -42.15700 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -39.94343 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 234 REMARK 465 GLU A 235 REMARK 465 PHE A 236 REMARK 465 LEU A 237 REMARK 465 GLY A 238 REMARK 465 ARG A 330 REMARK 465 ASN A 331 REMARK 465 LEU A 332 REMARK 465 GLN A 333 REMARK 465 GLY B 351 REMARK 465 GLU B 352 REMARK 465 PHE B 353 REMARK 465 LEU B 354 REMARK 465 GLY B 355 REMARK 465 ASN B 356 REMARK 465 VAL B 357 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 360 C - N - CA ANGL. DEV. = 10.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 255 -8.52 -147.96 REMARK 500 GLU A 271 22.09 -74.37 REMARK 500 TYR A 278 -4.83 -58.75 REMARK 500 LEU A 310 104.35 -58.04 REMARK 500 HIS A 313 55.99 -116.18 REMARK 500 ASN A 328 -107.91 -87.44 REMARK 500 CYS A 336 151.20 177.63 REMARK 500 SER A 345 137.99 -39.61 REMARK 500 PRO B 360 134.41 -20.98 REMARK 500 ARG B 379 -9.91 -59.38 REMARK 500 HIS B 401 136.74 -37.92 REMARK 500 ASN B 433 3.91 -65.81 REMARK 500 GLN B 434 5.99 84.34 REMARK 500 ASP B 452 64.27 -119.10 REMARK 500 GLU B 455 152.04 -48.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 72Q A 401 DBREF 5T0T A 239 346 UNP Q99814 EPAS1_HUMAN 239 346 DBREF 5T0T B 356 467 UNP P27540 ARNT_HUMAN 342 453 SEQADV 5T0T GLY A 234 UNP Q99814 EXPRESSION TAG SEQADV 5T0T GLU A 235 UNP Q99814 EXPRESSION TAG SEQADV 5T0T PHE A 236 UNP Q99814 EXPRESSION TAG SEQADV 5T0T LEU A 237 UNP Q99814 EXPRESSION TAG SEQADV 5T0T GLY A 238 UNP Q99814 EXPRESSION TAG SEQADV 5T0T GLU A 247 UNP Q99814 ARG 247 ENGINEERED MUTATION SEQADV 5T0T GLY B 351 UNP P27540 EXPRESSION TAG SEQADV 5T0T GLU B 352 UNP P27540 EXPRESSION TAG SEQADV 5T0T PHE B 353 UNP P27540 EXPRESSION TAG SEQADV 5T0T LEU B 354 UNP P27540 EXPRESSION TAG SEQADV 5T0T GLY B 355 UNP P27540 EXPRESSION TAG SEQADV 5T0T ARG B 362 UNP P27540 GLU 348 ENGINEERED MUTATION SEQRES 1 A 113 GLY GLU PHE LEU GLY LEU ASP SER LYS THR PHE LEU SER SEQRES 2 A 113 GLU HIS SER MET ASP MET LYS PHE THR TYR CYS ASP ASP SEQRES 3 A 113 ARG ILE THR GLU LEU ILE GLY TYR HIS PRO GLU GLU LEU SEQRES 4 A 113 LEU GLY ARG SER ALA TYR GLU PHE TYR HIS ALA LEU ASP SEQRES 5 A 113 SER GLU ASN MET THR LYS SER HIS GLN ASN LEU CYS THR SEQRES 6 A 113 LYS GLY GLN VAL VAL SER GLY GLN TYR ARG MET LEU ALA SEQRES 7 A 113 LYS HIS GLY GLY TYR VAL TRP LEU GLU THR GLN GLY THR SEQRES 8 A 113 VAL ILE TYR ASN PRO ARG ASN LEU GLN PRO GLN CYS ILE SEQRES 9 A 113 MET CYS VAL ASN TYR VAL LEU SER GLU SEQRES 1 B 117 GLY GLU PHE LEU GLY ASN VAL CYS GLN PRO THR ARG PHE SEQRES 2 B 117 ILE SER ARG HIS ASN ILE GLU GLY ILE PHE THR PHE VAL SEQRES 3 B 117 ASP HIS ARG CYS VAL ALA THR VAL GLY TYR GLN PRO GLN SEQRES 4 B 117 GLU LEU LEU GLY LYS ASN ILE VAL GLU PHE CYS HIS PRO SEQRES 5 B 117 GLU ASP GLN GLN LEU LEU ARG ASP SER PHE GLN GLN VAL SEQRES 6 B 117 VAL LYS LEU LYS GLY GLN VAL LEU SER VAL MET PHE ARG SEQRES 7 B 117 PHE ARG SER LYS ASN GLN GLU TRP LEU TRP MET ARG THR SEQRES 8 B 117 SER SER PHE THR PHE GLN ASN PRO TYR SER ASP GLU ILE SEQRES 9 B 117 GLU TYR ILE ILE CYS THR ASN THR ASN VAL LYS ASN SER HET 72Q A 401 26 HETNAM 72Q 3-{[(1S,2S,3R)-2,3-DIFLUORO-1-HYDROXY-7- HETNAM 2 72Q (METHYLSULFONYL)-2,3-DIHYDRO-1H-INDEN-4-YL]OXY}-5- HETNAM 3 72Q FLUOROBENZONITRILE FORMUL 3 72Q C17 H12 F3 N O4 S FORMUL 4 HOH *18(H2 O) HELIX 1 AA1 LEU A 239 SER A 241 5 3 HELIX 2 AA2 ARG A 260 GLY A 266 1 7 HELIX 3 AA3 HIS A 268 LEU A 273 5 6 HELIX 4 AA4 SER A 276 PHE A 280 5 5 HELIX 5 AA5 HIS A 282 GLY A 300 1 19 HELIX 6 AA6 ARG B 379 VAL B 384 1 6 HELIX 7 AA7 GLN B 387 LEU B 392 1 6 HELIX 8 AA8 ASN B 395 CYS B 400 5 6 HELIX 9 AA9 ASP B 404 LEU B 418 1 15 SHEET 1 AA1 5 PHE A 254 CYS A 257 0 SHEET 2 AA1 5 THR A 243 HIS A 248 -1 N GLU A 247 O TYR A 256 SHEET 3 AA1 5 CYS A 336 VAL A 343 -1 O CYS A 339 N SER A 246 SHEET 4 AA1 5 TYR A 316 ILE A 326 -1 N GLU A 320 O TYR A 342 SHEET 5 AA1 5 GLN A 301 VAL A 303 -1 N VAL A 302 O GLY A 323 SHEET 1 AA2 5 PHE A 254 CYS A 257 0 SHEET 2 AA2 5 THR A 243 HIS A 248 -1 N GLU A 247 O TYR A 256 SHEET 3 AA2 5 CYS A 336 VAL A 343 -1 O CYS A 339 N SER A 246 SHEET 4 AA2 5 TYR A 316 ILE A 326 -1 N GLU A 320 O TYR A 342 SHEET 5 AA2 5 TYR A 307 LEU A 310 -1 N TYR A 307 O LEU A 319 SHEET 1 AA3 5 PHE B 373 VAL B 376 0 SHEET 2 AA3 5 ARG B 362 HIS B 367 -1 N ARG B 366 O THR B 374 SHEET 3 AA3 5 TYR B 456 ASN B 463 -1 O ASN B 461 N PHE B 363 SHEET 4 AA3 5 TRP B 436 PHE B 446 -1 N PHE B 446 O TYR B 456 SHEET 5 AA3 5 LEU B 423 ARG B 430 -1 N PHE B 427 O MET B 439 SITE 1 AC1 18 PHE A 244 SER A 246 HIS A 248 MET A 252 SITE 2 AC1 18 ALA A 277 PHE A 280 TYR A 281 SER A 292 SITE 3 AC1 18 HIS A 293 LEU A 296 VAL A 302 SER A 304 SITE 4 AC1 18 TYR A 307 MET A 309 THR A 321 ILE A 337 SITE 5 AC1 18 ASN A 341 HOH A 502 CRYST1 73.416 84.314 41.574 90.00 106.10 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013621 0.000000 0.003931 0.00000 SCALE2 0.000000 0.011860 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025035 0.00000